About MitogenDx
Mitogen Diagnostics Corporation’s (MitogenDx) purpose is to make a positive impact on health and wellness through providing expertise in leading-edge diagnostic technologies. We embrace precision and companion health initiatives and are committed to providing actionable, patient-centered diagnostic information. Established in 1984, MitogenDx provides an ever-increasing spectrum of over 500 diagnostic targets specializing in autoimmune diagnostic tests and immune biomarkers.
Our goal is to HELP:
- MAKE AN EARLY and ACCURATE DIAGNOSIS
- PREVENT THE RAVAGES OF AUTOIMMUNE DISEASES
- GENERATE HIGH QUALITY DIAGNOSTIC INFORMATION to enable healthcare providers to respond with timely, efficient and effective treatment plans for their patients.
- LIMIT HEALTHCARE COSTS THROUGH SUSTAINABLE HEALTHCARE RESOURCES
SPECIALIZATION
MitogenDx specializes in the identification of novel autoantibodies and other biomarkers for autoimmune and related diseases. In turn, MitogenDx provides leading edge diagnostics by developing new tests for the detection of autoantibodies, autoantigens and related biomarkers in biological fluids. This includes characterization of antigens that react with sera of patients with systemic rheumatic and other autoinflammatory diseases, which has led to the development ofnovel diagnostic tests. A large part of MitogenDx’s R&D successes is due to the company’s intentional collaboration with diagnostic and therapeutic industry leaders.
Through MitogenDx’s diagnostic services the role of climate and environmental xenobiotics in the induction and perpetuation of autoimmunity are key considerations.
